Table 1.
Demographic and kidney disease-related characteristics
| Characteristic | Value |
|---|---|
|
| |
| Age, y (median, IQR) | 15.4 [12.1, 18] |
|
| |
| Male (%, n) | 62% (403) |
|
| |
| African-American race (%, n) | 22% (140) |
|
| |
| Low birth weight (<2500 g) (%, n) | 19% (117) |
|
| |
| BMI percentile (median, IQR) | 64 [31, 90] |
|
| |
| eGFR (median, IQR) | 47 [30, 64] |
|
| |
| Nephrotic proteinuria (uP/C > 2) (%, n) | 18% (107) |
|
| |
| Glomerular etiology (%, n) | 26% (167) |
|
| |
| Percent of life with CKD (median, IQR) | 100% [82%, 100%] |
|
| |
| Years in study (median, IQR) | 4.0 [2.1, 6.1] |
|
| |
| Number of study visits (median, IQR) | 6 [4, 8] |
|
| |
| SBP Index (median, IQR) | 0.87 [0.83, 0.92] |
|
| |
| DBP Index (median, IQR) | 0.82 [0.76, 0.88] |
|
| |
| SBP or DBP ≥ 90th percentile | |
| at most recent visit | 152 (24%) |
| at any study visit | 385 (59%) |
|
| |
| Antihypertensive medication use (any) | 463 (71%) |
| ACE inhibitor/ARB | 363 (56%) |
| Calcium Channel Blocker | 119 (18%) |
| Other | 102 (16%) |
ACE: Angiotensin converting enzyme, ARB: Angiotensin receptor blocker, BMI: Body mass index, CKD: chronic kidney disease, DBP: diastolic blood pressure, eGFR: estimated glomerular filtration rate, IQR: interquartile range, SBP: systolic blood pressure